In reviewing FDA's Warning Letters from the calendar year 2013, it has been found that 9 Warning Letters contained observations with reagrd to GMP/FDA complaint handling of OOS results. As a matter of fact, the handling of OOS results remains one of the most critical aspects during an FDA inspection. The most important citations from the Warning Letters can be found in this News.
